Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations
Renal cell carcinoma (RCC) incidence is higher among black than white Americans. The reasons for this disparity remain unclear.
We calculated race- and sex-specific population attributable risk percentages (PAR%) and their 95% confidence intervals (CI) for hypertension and chronic kidney disease (CKD) among black and white subjects ≥ 50 years of age from the US Kidney Cancer Study (USKC; 965 cases, 953 controls), a case–control study in Chicago and Detroit, and a nested case–control study in the Kaiser Permanente Northern California health care network (KPNC; 2,162 cases, 21,484 controls). We also estimated PAR% for other modifiable RCC risk factors (cigarette smoking, obesity) in USKC.
In USKC, the PAR% for hypertension was 50% (95% CI 24–77%) and 44% (95% CI 25–64%) among black women and men, respectively, and 29% (95% CI 13–44%) and 27% (95% CI 14–39%) for white women and men, respectively. In KPNC, the hypertension PAR% was 40% (95% CI 18–62%) and 23% (95% CI 2–44%) among black women and men, and 27% (95% CI 20–35%) and 19% (95% CI 14–24%) among white women and men, respectively. The PAR% for CKD in both studies ranged from 7 to 10% for black women and men but was negligible (<1%) for white subjects. In USKC, the PAR% for current smoking was 20% and 8% among black and white men, respectively, and negligible and 8.6% for black and white women, respectively. The obesity PAR% ranged from 12 to 24% across all race/sex strata.
If the associations found are causal, interventions that prevent hypertension and CKD among black Americans could potentially eliminate the racial disparity in RCC incidence (hypothetical black:white RCC incidence ratio of 0.5).
KeywordsKidney cancer African Americans Hypertension Chronic kidney disease Population attributable risk
This work was supported by the Intramural Research Program of the US National Cancer Institute (NCI), National Institutes of Health (NIH).
- 3.Cutler JA, Sorlie PD, Wolz M et al (2008) Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension 52(5):818–827. https://doi.org/10.1161/HYPERTENSIONAHA.108.113357 CrossRefPubMedGoogle Scholar
- 4.Centers for Disease Control and Prevention (CDC) (2007) Prevalence of chronic kidney disease and associated risk factors—United States, 1999–2004. MMWR Morb Mortal Wkly Rep 56(8):161–165Google Scholar
- 11.Gago-Dominguez M, Castelao JE (2006) Lipid peroxidation and renal cell carcinoma: further supportive evidence and new mechanistic insights. Free Radic Biol Med 40(4):721–733. https://doi.org/10.1016/j.freeradbiomed.2005.09.026 CrossRefPubMedGoogle Scholar
- 15.Surveillance E, End Results (SEER) Program (www.seer.cancer.gov). Research data. In: National Cancer Institute D, Surveillance Research Program, ed. based on the November 2016 submission ed, 1973–2014